Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Eternal Materials Co., Ltd. (1717.TW)
Kaohsiung, TW
Eternal Materials Co., Ltd., established in 1964 and based in Kaohsiung, Taiwan, is a leading producer and distributor of a broad spectrum of chemical products, encompassing resin, high-performance, and electronic materials. The company, which was formerly known as Eternal Chemical Co., Ltd. before its rebranding in 2014, offers a diverse portfolio for various industries. Their extensive range of resin materials includes polyester polyol, polyurethane, alkyd, both solvent and water-based acrylic coating resins, amino, fluorocarbon, saturated and unsaturated polyesters, vinyl ester, and fire retardant coatings. Additionally, they manufacture acrylic resins tailored for adhesives and overprinting applications. Beyond traditional resins, the company provides advanced solutions like optoelectronic materials, photovoltaic materials, epoxy systems, structural adhesives, and specialized polyesters used in polyurethane foam. They also supply UV monomers and oligomers, unique coatings, silicone powders, various additives, and cutting-edge materials for 3D UV printing. A significant part of their offerings caters to the electronics sector, featuring a comprehensive selection of printed circuit board (PCB) materials. This includes dry film photoresists, dry film solder masks, UV inks, dry film photosensitive polyimides, paper phenolic copper clad laminates, and composite epoxy copper clad laminates. For flat panel displays and touch panels, they furnish dry film photoresists, liquid polyimide materials, prism films, and protective films. Complementing these products, Eternal Materials also provides vacuum laminating and toll coating services. The firm's expertise further extends into biomedical materials, covering biochemical and molecular diagnostics, recombinant proteins, and antibodies. Other specialized products within their catalogue include liquid molding compounds for wafer-level packaging (WLP), solid capacitor materials, lithium battery components, green process-less CTP plate photoresist, thermoplastic composites, and hydrophilic films. Eternal Materials' innovative products are extensively utilized across diverse sectors such as energy, transportation, construction and furniture, electronics, consumer goods, packaging and printing, healthcare and medical, and metal machinery. The company boasts a significant international footprint, with operations spanning Taiwan, China, Japan, Vietnam, Thailand, the United States, India, Indonesia, Malaysia, Korea, and Italy.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -6.35% | -7.18% | -9.01% | +24.49% | +86.82% | +80.20% | +183.46% | +125.73% | +109.61% | +165.11% | +874.87% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 2 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%-7.9% Q1'26: +1.8% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%-9.0% Q1'26: +20.0% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+2.6% Q1'26: +3.4% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+4.2% Q1'26: +5.1% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+2.8% Q1'26: +3.3% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%-0.4% ★ Q1'26: -0.7% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×5.59× Q1'26: 4.63× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 2 Rev. Ana. 2 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
38.49B
est: 38.47B (+0.0%)
|
38.68B
est: 38.75B (-0.2%)
|
41.55B
est: 41.82B (-0.6%)
|
43.30B
est: 43.45B (-0.3%)
|
40.36B
est: 44.92B (-10.1%)
|
38.37B
est: 36.37B (+5.5%)
|
50.47B
est: 50.44B (+0.1%)
|
49.01B
est: 51.40B (-4.6%)
|
42.45B
est: 42.45B (0.0%)
|
44.19B
est: 44.79B (-1.3%)
|
40.68B
est: 40.69B (0.0%)
|
47.57B
44.94B – 50.19B
+16.9% YoY
|
49.10B
47.77B – 50.42B
+3.2% YoY
|
| EBITDA |
5.14B
est: 4.83B (+6.3%)
|
4.94B
est: 4.87B (+1.4%)
|
4.30B
est: 5.25B (-18.1%)
|
4.11B
est: 5.46B (-24.7%)
|
5.43B
est: 5.64B (-3.7%)
|
5.57B
est: 4.57B (+21.9%)
|
6.84B
est: 6.34B (+7.9%)
|
5.96B
est: 6.46B (-7.7%)
|
4.74B
est: 5.33B (-11.1%)
|
5.05B
est: 5.20B (-3.0%)
|
3.97B
est: 4.72B (-16.0%)
|
5.52B
5.22B – 5.83B
+16.9% YoY
|
5.70B
5.55B – 5.85B
+3.2% YoY
|
| EBIT |
3.65B
est: 3.00B (+21.4%)
|
3.31B
est: 3.02B (+9.4%)
|
2.49B
est: 3.26B (-23.6%)
|
2.25B
est: 3.39B (-33.7%)
|
3.41B
est: 3.51B (-2.6%)
|
3.53B
est: 2.84B (+24.3%)
|
4.72B
est: 3.94B (+20.0%)
|
3.87B
est: 4.01B (-3.4%)
|
2.64B
est: 3.31B (-20.4%)
|
2.81B
est: 3.04B (-7.8%)
|
1.69B
est: 2.77B (-38.8%)
|
3.23B
3.05B – 3.41B
+16.9% YoY
|
3.34B
3.25B – 3.43B
+3.2% YoY
|
| Net Income |
2.87B
est: 2.47B (+16.2%)
|
2.63B
est: 2.90B (-9.5%)
|
1.91B
est: 1.88B (+1.8%)
|
1.55B
est: 1.69B (-8.2%)
|
2.47B
est: 1.98B (+24.4%)
|
2.54B
est: 2.47B (+2.9%)
|
3.55B
est: 3.70B (-4.0%)
|
2.62B
est: 4.09B (-36.0%)
|
1.50B
est: 1.58B (-5.1%)
|
1.83B
est: 1.71B (+7.4%)
|
1.66B
est: 1.68B (-1.7%)
|
2.55B
2.50B – 2.60B
+51.3% YoY
|
3.16B
3.04B – 3.27B
+23.9% YoY
|
| SGA |
3.93B
est: 4.17B (-5.7%)
|
4.05B
est: 4.20B (-3.5%)
|
4.26B
est: 4.53B (-5.9%)
|
4.10B
est: 4.71B (-13.0%)
|
4.19B
est: 4.87B (-13.9%)
|
4.26B
est: 3.94B (+8.2%)
|
5.08B
est: 5.47B (-7.1%)
|
5.21B
est: 5.57B (-6.5%)
|
4.68B
est: 4.60B (+1.8%)
|
5.02B
est: 4.93B (+1.8%)
|
4.86B
est: 4.48B (+8.5%)
|
5.23B
4.94B – 5.52B
+16.9% YoY
|
5.40B
5.26B – 5.55B
+3.2% YoY
|
| EPS |
2.44
est: 2.09 (+16.7%)
|
2.23
est: 2.46 (-9.2%)
|
1.62
est: 1.59 (+2.1%)
|
1.32
est: 1.43 (-7.6%)
|
2.09
est: 1.68 (+24.6%)
|
2.16
est: 2.09 (+3.3%)
|
3.01
est: 3.13 (-3.7%)
|
2.15
est: 3.46 (-37.8%)
|
1.28
est: 1.34 (-4.5%)
|
1.56
est: 1.45 (+7.6%)
|
1.41
est: 1.43 (-1.4%)
|
2.16
2.12 – 2.21
+51.3% YoY
|
2.68
2.59 – 2.77
+23.9% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-15 | C+ | 2/5 | 2/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-14 | B- | 3/5 | 2/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-13 | B- | 3/5 | 2/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-12 | B- | 3/5 | 2/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-11 | B- | 3/5 | 2/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-08 | B- | 3/5 | 2/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-07 | B- | 3/5 | 2/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-06 | B- | 3/5 | 2/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-05 | B | 3/5 | 3/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-04 | B | 3/5 | 3/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-30 | B | 3/5 | 3/5 | 3/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-29 | B | 3/5 | 3/5 | 3/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-28 | B | 3/5 | 3/5 | 3/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-27 | B | 3/5 | 3/5 | 3/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-24 | B | 3/5 | 3/5 | 3/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-23 | B | 3/5 | 3/5 | 3/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-22 | B | 3/5 | 3/5 | 3/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-21 | B | 3/5 | 3/5 | 3/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-20 | B | 3/5 | 3/5 | 3/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-17 | B | 3/5 | 3/5 | 3/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-16 | B | 3/5 | 3/5 | 3/5 | 5/5 | 1/5 | 2/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | WisdomTree Emerging Markets SmallCap Dividend UCITS ETF DGSD.L | 0.27% | 119.0K | 0.54% |
| 2 | JPMorgan Diversified Return Emerging Markets Equity ETF JPEM | 0.22% | 854.8K | 0.44% |
| 3 | WisdomTree Emerging Markets SmallCap Dividend Fund DGS | 0.22% | 3.93M | 0.58% |
| 4 | Avantis Emerging Markets Small Cap Equity ETF AVEE | 0.19% | 231.7K | 0.42% |
| 5 | iShares MSCI AC Far East ex-Japan Small Cap UCITS ETF ISFE.L | 0.17% | 124.6K | 0.74% |
| 6 | State Street SPDR S&P Emerging Markets Small Cap ETF EWX | 0.17% | 1.21M | 0.65% |
| 7 | State Street SPDR MSCI Emerging Markets Small Cap UCITS ETF EMSD.L | 0.12% | 751.5K | 0.55% |
| 8 | iShares MSCI EM Small Cap UCITS ETF IEMS.L | 0.11% | 396.1K | 0.74% |
| 9 | iShares MSCI Emerging Markets Small-Cap ETF EEMS | 0.11% | 395.4K | 0.72% |
| 10 | Franklin FTSE Taiwan ETF FLTW | 0.09% | 2.72M | 0.19% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Kuo-Lun Kao | President, Chairman & CEO | 21M | male |
| Heng-Ning Liao | Vice President, Chief Technology Officer, Chief Operating Officer of Business Unit & Director | 2M | male |
| Chin-Yuan Chen | Vice President, Chief Technology Officer, Chief Operating Officer of Business Unit & Director | 2M | male |
| Shun-Jen Huang | Chief Technology Officer & Director | 1M | — |
| Hung-Yi Chen | Chief Operating Officer of Southeast Asia Operation | — | — |
| Jui-Hsin Chu | Chief Information Security Officer,Chief Administration Officer, AVP & Director of Administration | — | female |
| Hui-Fang Su | Accounting Manager & Chief Accounting Officer | — | female |
| Chao-Cheng Hung | Chief Operating Officer of New Business Development Unit | — | — |
| Chin-Cheng Pan | Vice President, Chief Operating Officer of High Performance Materials Division & COO of Mainland China Operation Center | — | male |
| Bing-Cheng Liu | Chief Financial Officer, Chief Corporate Governance Officer & Company Secretary | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 1717.TW
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
